Solid Tumor Cancer
Oncology
2
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2025
2026
2027
2028
2029
2030
2031
InxMedIN10018 in combination with RNK08954
Abdera Therapeutics111In-ABD147
Clinical Trials (2)
Total enrollment: 92 patients across 2 trials
IN10018 in Combination With RNK08954 for the Treatment of KRASG12D Mutation-Positive Locally Advanced or Metastatic Solid Tumors
Start: Feb 2026Est. completion: Feb 203192 patients
Phase 1/2Recruiting
Imaging of Solid Tumors Using DLL3 SPECT
Start: Nov 2025Est. completion: Dec 2027
Phase 1Not Yet Recruiting
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
1m ago
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
1m ago
Office Administrator
SystImmune
1m ago
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
11m ago
Working Student Office Management Support (m/f/d)
Mindpeak
Hamburg
15m ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
15m ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 92 patients
2 companies competing in this space